-------------------------------------
OMB APPROVAL
-------------------------------------
OMB Number: 3235-0145
Expires: October 31, 1997
Estimated average burden
hours per response..........14.90
-------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
PCI SERVICES, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $.001 PER SHARE
(Title of Class of Securities)
693206 10 4
(CUSIP Number)
F. Douglas Raymond, III
Drinker Biddle & Reath
Philadelphia National Bank Building
1345 Chestnut Street
Philadelphia, PA 19107
(215) 988-2700
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
March 29, 1996
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box .
Check the following box if a fee is being paid with the statement , (A fee is
not required only if the reporting person (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
SEC 1746 (12-91)
PHTRANS:92619_3.WP5
<PAGE>
SCHEDULE 13D
<TABLE>
<S> <C> <C> <C>
- ---------------------------------------------- ----------------------------------------------
CUSIP No. 693 206 104 Page 2 of 6 Pages
- ---------------------------------------------- ----------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MEDIQ Incorporated
IRS Identification No. 51-0219413*
- -----------------------------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)
(b)
- -----------------------------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
00
- -----------------------------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
- -----------------------------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -----------------------------------------------------------------------------------------------------------------------------
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH -0-
REPORTING PERSON
WITH
------------------------------------------------------------------------------------------
8 SHARED VOTING POWER
2,875,000
------------------------------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
-0-
------------------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,875,000
- -----------------------------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,875,000
- -----------------------------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*
- -----------------------------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
46.9%
- -----------------------------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- -----------------------------------------------------------------------------------------------------------------------------
</TABLE>
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
PHTRANS:92619_3.WP5
<PAGE>
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
SCHEDULE 13D
<TABLE>
<S> <C> <C> <C>
- ---------------------------------------------- ----------------------------------------------
CUSIP No. 693 206 104 Page 3 of 6 Pages
- ---------------------------------------------- ----------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MEDIQ Investment Services, Inc.
IRS Identification No. 51-0261761
- -----------------------------------------------------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)
(b)
- -----------------------------------------------------------------------------------------------------------------------------
3. SEC USE ONLY
- -----------------------------------------------------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
00
- -----------------------------------------------------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
- -----------------------------------------------------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -----------------------------------------------------------------------------------------------------------------------------
NUMBER OF SHARES 7. SOLE VOTING POWER
BENEFICIALLY
OWNED BY EACH -0-
REPORTING PERSON
WITH
------------------------------------------------------------------------------------------
8. SHARED VOTING POWER
2,875,000
------------------------------------------------------------------------------------------
9. SOLE DISPOSITIVE POWER
-0-
------------------------------------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
2,875,000
- -----------------------------------------------------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,875,000
- -----------------------------------------------------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*
- -----------------------------------------------------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
46.9%
- -----------------------------------------------------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON*
CO
- -----------------------------------------------------------------------------------------------------------------------------
</TABLE>
PHTRANS:92619_3.WP5
<PAGE>
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
-4-
PHTRANS:92619_3.WP5
<PAGE>
The statement on Schedule 13D (the "Original Schedule 13D")
dated September 9, 1992, filed with the Securities and Exchange Commission by
MEDIQ Incorporated ("MEDIQ") and MEDIQ Investment Services, Inc. ("MIS", and
together with MEDIQ, the "Reporting Persons") with respect to beneficial
ownership of Common stock, par value $.001 per share (the "Common Stock"), of
PCI Services, Inc. (the "Issuer") is hereby amended as provided herein.
Item 2. Identity and Background. Item 2 is amended by adding
the following:
The names, business or residence addresses and present
principal occupations of the directors and executive officers of the Reporting
Persons are attached on Schedule I. All such persons are citizens of the United
States. During the last five years, none of the Reporting Persons or such
persons have been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors); or have been a party to a civil proceeding
of a judicial or administrative body of competent jurisdiction resulting in a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
Item 4. Purpose of Transaction. Item 4 is amended in its
entirety and restated to read as follows:
In January and February, 1996, representatives of MEDIQ met
with management of the Issuer further to explore how best to accomplish MEDIQ's
previously announced intention to realize the value of its investment in the
Issuer by a sale of its shares of the Issuer's capital stock or other
transaction, and to establish a process for realizing this value in a manner
that could be shared by all of the Company's stockholders. As a result of these
meetings, a representative from MEDIQ'S board of directors was invited to
participate with the Issuer and the Issuer's investment bankers in exploring
strategic alternatives available to the Issuer, including a possible sale of the
Issuer.
In addition, following these meetings and in response to a
request by MEDIQ, the board of directors of the Issuer nominated for election as
directors of the Issuer, for election at the 1996 annual meeting of the Issuer's
stockholders, six individuals, three of whom were existing directors of the
Issuer and the other three of whom, Michael J. Rotko, Sheldon M. Bonovitz and H.
Scott Miller, presently are directors of MEDIQ (and in the case of Mr. Rotko,
Chairman of the Board of Directors). These individuals were elected as directors
of the Issuer at the Issuer's 1996 Annual Meeting, held March 29, 1996.
-5-
PHTRANS:92619_3.WP5
<PAGE>
The Reporting Persons do not believe that they have formed a
"group" as defined by Rule 13d-5(b)(1) to the Securities and Exchange Act of
1934 with any person, and expressly disclaim that they are members of any such
group.
The Reporting Persons have no immediate intentions regarding
any plans or proposals which relate to or which would result in any of the
actions specified in clauses (a) through (j) of Item 4 of Schedule 13D, except
as described herein. However, the Reporting Persons intend to review on a
continuing basis their investment in the Issuer and may in the future alter
their intentions.
Item 5. Interest in Securities of the Issuer. Item 5 is amended by deleting
paragraph (a) in its entirety and inserting in lieu thereof the following:
(a) As of the date hereof, MEDIQ and MIS are the beneficial owners of 2,875,000
shares of Common Stock. Based upon the Issuer's Report on Form 10-K for the year
ended September 30, 1995, 6,126,250 shares of Common Stock were outstanding on
December 1, 1995. MEDIQ and MIS' Common Stock holdings represent approximately
46.9% of the shares of Common Stock outstanding. Information regarding the
beneficial ownership of shares of common stock by the persons identified on
Schedule 1 hereto is set forth on such schedule.
-6-
PHTRANS:92619_3.WP5
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement
is true, complete and correct.
Dated: April 23, 1996
MEDIQ INCORPORATED
/s/ Michael F. Sandler
---------------------------------
Michael F. Sandler
Chief Financial Officer
MEDIQ INVESTMENT SERVICES, INC.
/s/ Michael F. Sandler
----------------------------------
Michael F. Sandler
Chief Financial Officer
-7-
PHTRANS:92619_3.WP5
<PAGE>
SCHEDULE I
<TABLE>
<CAPTION>
Name, Business or Residence Ownership of Shares of
Addresses* Principal Occupation Common Stock of the Issuer
- --------------------------- -------------------- --------------------------
<S> <C> <C>
Michael J. Rotko, Esquire** Partner, Drinker Biddle & Reath, a -0-
Philadelphia National Bank Bldg. law firm, a Director and Chairman of
1345 Chestnut Street MEDIQ and a Director of the Issuer
Philadelphia, PA 19107-3496
Jacob A. Shipon** Physician, Director of MEDIQ -0-
5200 E. Roosevelt Boulevard
Philadelphia, PA 19124
Thomas E. Carroll President and Chief Executive -0-
Officer and a Director of MEDIQ
and MIS
Michael F. Sandler Vice President and Chief Financial 28,000
Officer of Issuer; Senior Vice
President, Finance and Chief
Financial Officer and Treasurer and a
Director of MEDIQ
Sheldon M. Bonovitz, Esquire Partner, Duane, Morris & 50
Duane, Morris & Heckscher Heckscher, a law firm, a Director of
4200 One Liberty Place MEDIQ and a Director of the Issuer
Philadelphia, PA 19103
Lionel Felzer Retired; a Director of MEDIQ -0-
Breyer Woods
412 Linden Drive
Elkins Park, PA 19027
Mark S. Levitan Vice President -- Consulting -0-
529 Spring Mill Road Division, MedQuist Inc. and a
Villanova, PA 19085 Director of MEDIQ
H. Scott Miller President, Miller International 4,000
Pulsar Equity Partners Associates, Inc., a Director
One Tower Bridge of MEDIQ and a Director of the
West Conshohocken, PA 19428 Issuer
</TABLE>
* If not otherwise indicated, the business address of each person is One
Mediq Plaza, Pennsauken, NJ 08110-1460.
** Mr. Rotko, together with his mother, Bessie G. Rotko, Judith M. Shipon (the
spouse of Jacob A. Shipon), John Iskrant and PNC Bank, N.A., are trustees
of a Trust which owns 3,570,969 shares of the Common Stock, and 3,570,969
shares of the Preferred Stock of MEDIQ. The Trustees share voting and
investment power with respect to such shares.
-8-
PHTRANS:92619_3.WP5
<PAGE>
